课题基金 / 基金详情

Characterization of Intestinal Microbiota and its Interaction with Diet in Diabetes Type 2, Non-Alcoholic Fatty Liver Disease and Colon Cancer

Characterization of Intestinal Microbiota and its Interaction with Diet in Diabetes Type 2, Non-Alcoholic Fatty Liver Disease and Colon Cancer
2 型糖尿病、非酒精性脂肪肝和结肠癌肠道微生物群的特征及其与饮食的相互作用
批准号:
196722
负责人:
Allard Johane P
金额:
$0.0万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-11-01 至 2009-11-01

项目摘要

项目成果

Allard Johane P的其他基金

相似基金

相关文献

中文摘要
翻译
新的文献表明,肠道微生物群(IM)的组成,即肠道中细菌的混合物,可能在肥胖和相关疾病中发挥作用,如2型糖尿病(DT2),非酒精性脂肪肝(NAFLD)和糖尿病。
英文摘要
New literature suggests that the composition of the intestinal microbiota (IM), the mix of bacteria residing in the intestine, could play a role in obesity and related diseases such as diabetes type 2 (DT2), non-alcoholic fatty liver disease (NAFLD) and c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessing the role and preventative or therapeutic effects of Faecalibacterium prausnitzii and other candidate bacteria in non-alcoholic fatty liver disease
  • 批准号:
    398980
  • 项目类别:
    Operating Grants
  • 资助金额:
    $1.82万
  • 财政年份:
    2018
  • 负责人:
    Allard Johane P
  • 依托单位:
Exploiting the therapeutic effects of the fecal microbiome in bariatric care
  • 批准号:
    315242
  • 项目类别:
    Operating Grants
  • 资助金额:
    $100.17万
  • 财政年份:
    2014
  • 负责人:
    Allard Johane P
  • 依托单位:
Role of intestinal microbiota in non-alcoholic fatty liver disease pre and post bariatric surgery
  • 批准号:
    266811
  • 项目类别:
    Operating Grants
  • 资助金额:
    $38.04万
  • 财政年份:
    2012
  • 负责人:
    Allard Johane P
  • 依托单位:
Non-Alcoholic Fatty Liver Disease: Role of Intestinal Microbiota and n-3 Polyunsaturated Fatty Acid Supplementation
  • 批准号:
    253329
  • 项目类别:
    Operating Grants
  • 资助金额:
    $26.45万
  • 财政年份:
    2012
  • 负责人:
    Allard Johane P
  • 依托单位:
海外基金